EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patients

Roman Mayr, Simon Udo Engelmann, Yushan Yang, Maximilian Haas, Thomas Schmid, Marco Julius Schnabel, Johannes Breyer, Daniel Schmidt, Matthias Eiber, Stefan Denzinger, Maximilian Burger, Dirk Hellwig und 2 weitere

World Journal of Urology · 2024

DOI: 10.1007/s00345-024-05189-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, 2024. Verfasst von Roman Mayr und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, St. Josef Medical Center, University of Regensburg, Landshuter Straße 65, 93053, Regensburg, Germany. roman.mayr@ukr.de. Hauptthemen laut MEDLINE: Salvage Therapy, Prostatic Neoplasms, Neoplasm Recurrence, Local, Lymph Node Excision. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Regensburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The higher detection efficacy of PSMA PET for oligometastatic recurrence of prostate cancer has promoted new loco-regional treatment options. PSMA-targeted radioguided surgery (PSMA-RGS) was introduced to facilitate salvage surgery of small tumor deposits. The objectives of this retrospective analysis are to describe an independent single-center consecutive cohort of patients undergoing PSMA-RGS and to evaluate its clinical and oncological outcomes.

Method

Between 2018 and 2022, 53 patients were treated with PSMA-RGS and 50 patients were available for final analyses. All patients were initially treated with radical prostatectomy (RP) and presented with biochemical recurrence (BCR) with at least one positive lesion on PSMA-PET imaging. After preparation of 99mTc-PSMA-I&S and intravenous injection, surgery was performed by using a gamma-probe intraoperatively.

Results

Median age was 70 years (IQR 65–73) and the median PSA at salvage surgery was 1.2 ng/mL (IQR 0.6-3.0). In all patients pathologically positive lesions could be removed during PSMA-RGS. 29 (58%) patients had one pathologically positive lesion, 14 (28%) had two and 7 (14%) had three or more, respectively. The overall complication rate was 26% with 4 (8%), 1 (2%), and 8 (16%) having Clavien-Dindo (CD) type I, II, and IIIb complications, respectively. During the follow-up period 31 (62%) patients experienced BCR and 29 (58%) received further therapy.

Conclusions

PSMA-RGS is a promising treatment option to enhance salvage surgery in early biochemical recurrence. However, only 42% of the patients treated with PSMA RGS remain without a biochemical recurrence. Further research is mandatory to identify patients, who profit from PSMA-RGS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salvage TherapyProstatic NeoplasmsNeoplasm Recurrence, LocalLymph Node ExcisionSurgery, Computer-AssistedHumansMaleAgedRetrospective StudiesProstate-Specific AntigenProstatectomyLymphatic Metastasis

Stichwörter der Autor:innen

Metastasis directed therapyOligometastasisProstate cancer

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, St. Josef Medical Center, University of Regensburg, Landshuter Straße 65, 93053, Regensburg, Germany. roman.mayr@ukr.de.
  • Department of Urology, St. Josef Medical Center, University of Regensburg, Landshuter Straße 65, 93053, Regensburg, Germany.
  • Department of Nuclear Medicine, University of Regensburg, 93053, Regensburg, Germany.
  • Department of Nuclear Medicine, School of Medicine, Technical University Munich, Munich, Germany.

Förderung

  • Universitätsklinikum Regensburg

Zitieren

APA

Mayr, R., Engelmann, S. U., Yang, Y., Haas, M., Schmid, T., Schnabel, M. J., Breyer, J., Schmidt, D., Eiber, M., Denzinger, S., Burger, M., Hellwig, D., Moosbauer, J., & Grosse, J. (2024). Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patients. World Journal of Urology. https://doi.org/10.1007/s00345-024-05189-6

Vancouver

Mayr R, Engelmann SU, Yang Y, Haas M, Schmid T, Schnabel MJ, et al. Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patients. World Journal of Urology. 2024. doi:10.1007/s00345-024-05189-6

BibTeX
@article{Mayr2024,
  author = {Mayr, Roman and Engelmann, Simon Udo and Yang, Yushan and Haas, Maximilian and Schmid, Thomas and Schnabel, Marco Julius and Breyer, Johannes and Schmidt, Daniel and Eiber, Matthias and Denzinger, Stefan and Burger, Maximilian and Hellwig, Dirk and Moosbauer, Jutta and Grosse, Jirka},
  title = {Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patients},
  journal = {World Journal of Urology},
  year = {2024},
  doi = {10.1007/s00345-024-05189-6}
}
Kostenlos starten →